Morelle, J, Marechal, C, Yu, Z, Debaix, H, Corre, T, Lambie, M, Verduijn, M, Dekker, F, Bovy, P, Evenepoel, P, Bammens, B, Selgas, R, Bajo, MA, Coester, AM, Sow, A, Hautem, N, Struijk, DG, Krediet, RT, Balligand, J-L, Goffin, E, Crott, R, Ripoche, P, Davies, SJ ORCID: https://orcid.org/0000-0001-5127-4755 and Devuyst, O (2021) AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis. New England Journal of Medicine, 385 (17). 1570 - 1580.

[img] Text
Morelle--Devuyst--20-34279-Text.docx - Accepted Version
Restricted to Repository staff only

Download (498kB)

Abstract

BACKGROUND: Variability in ultrafiltration influences prescriptions and outcomes in patients with kidney failure who are treated with peritoneal dialysis. Variants in AQP1, the gene that encodes the archetypal water channel aquaporin-1, may contribute to that variability. METHODS: We gathered clinical and genetic data from 1851 patients treated with peritoneal dialysis in seven cohorts to determine whether AQP1 variants were associated with peritoneal ultrafiltration and with a risk of the composite of death or technique failure (i.e., transfer to hemodialysis). We performed studies in cells, mouse models, and samples obtained from humans to characterize an AQP1 variant and investigate mitigation strategies. RESULTS: The common AQP1 promoter variant rs2075574 was associated with peritoneal ultrafiltration. Carriers of the TT genotype at rs2075574 (10 to 16% of patients) had a lower mean (±SD) net ultrafiltration level than carriers of the CC genotype (35 to 47% of patients), both in the discovery phase (506±237 ml vs. 626±283 ml, P = 0.007) and in the validation phase (368±603 ml vs. 563±641 ml, P = 0.003). After a mean follow-up of 944 days, 139 of 898 patients (15%) had died and 280 (31%) had been transferred to hemodialysis. TT carriers had a higher risk of the composite of death or technique failure than CC carriers (adjusted hazard ratio, 1.70; 95% confidence interval [CI], 1.24 to 2.33; P = 0.001), as well as a higher risk of death from any cause (24% vs. 15%, P = 0.03). In mechanistic studies, the rs2075574 risk variant was associated with decreases in AQP1 promoter activity, aquaporin-1 expression, and glucose-driven osmotic water transport. The use of a colloid osmotic agent mitigated the effects of the risk variant. CONCLUSIONS: A common variant in AQP1 was associated with decreased ultrafiltration and an increased risk of death or technique failure among patients treated with peritoneal dialysis. (Funded by the Swiss National Science Foundation and others.).

Item Type: Article
Additional Information: The final version of this accepted manuscript and all relevant information related to it, including copyrights, can be found online via the publisher website at; https://www.nejm.org/doi/10.1056/NEJMoa2034279 The accepted version is required to stay under embargo due to publisher requirements. When the published version is available, that is able to be used.
Subjects: R Medicine > R Medicine (General)
R Medicine > R Medicine (General) > R735 Medical education. Medical schools. Research
R Medicine > RC Internal medicine > RC902 Nephrology
Divisions: Faculty of Medicine and Health Sciences > School of Medicine
Related URLs:
Depositing User: Symplectic
Date Deposited: 26 Oct 2021 15:37
Last Modified: 26 Oct 2021 15:37
URI: https://eprints.keele.ac.uk/id/eprint/10184

Actions (login required)

View Item View Item